Mounjaro® and burping

Eructation in the Mounjaro® numbers

Eructation is the medical word for a burp: air moving up from the stomach and out through the mouth ^[9]. In the US label it is not in Table 1, which only lists reactions seen in at least 5% of people; it appears in the text below, among stomach reactions that were more frequent than on placebo ^[1]. The pool behind those numbers is SURPASS-1 and SURPASS-5, 718 adults with type 2 diabetes on tirzepatide for an average of 36.6 weeks ^[1].

A small rate, a large ratio

About 3 in 100 people on Mounjaro® reported burping, compared with roughly 1 in 250 on placebo. The absolute number is small, but the gap is about six- to eightfold, which is why the label counts it as drug-related ^[1]. In the seven-trial pool, with more than 1,700 people per dose and longer exposure, the rate climbs gently with dose ^[4].

The same molecule is sold for weight reduction as Zepbound®, and its label reports burping at 4% to 5% against 1% on placebo in adults with obesity ^[10]. The two programmes enrolled different people with different doses and background treatments, so the figures should not be compared directly, but both point the same way.

Burping sits next to other upper-stomach complaints. Indigestion (dyspepsia) was reported by 8%, 8% and 5% on Mounjaro® against 3% on placebo, and reflux by 1.7% to 2.5% against 0.4% ^[1]. A person with a full, sour upper stomach may tick several of these at once; the separate Mounjaro® heartburn page covers reflux and indigestion in detail.

What report databases add

Two studies of the US FDA Adverse Event Reporting System looked at tirzepatide after approval. One found nausea and diarrhea to be the stomach complaints reported most often, but eructation and impaired gastric emptying the ones most over-represented compared with other medicines; most stomach reports came within three months, with a median of 16 days ^[5]. The other, covering more than 123,000 reports to the end of 2025, listed eructation among new signals worth further study, alongside hunger and food craving ^[6].

These databases rely on voluntary reports from patients and professionals. They can show which complaints stand out, but not how often they happen, and they cannot prove the medicine caused them ^[5][6].

Why a slower stomach can bring up air

What the label supports: tirzepatide delays stomach emptying, most strongly after the first dose, and this effect becomes smaller with later doses ^[1]. Europe lists delayed gastric emptying among uncommon side effects ^[3]. The label does not connect this directly to burping.

What general sources describe: a burp happens when swallowed air stretches the stomach and the valve at the lower end of the food pipe relaxes to let it out ^[9]. Cleveland Clinic lists a slow stomach, indigestion and reflux among conditions that can make belching more frequent ^[9]. Gas can also come from gut bacteria breaking down food that was not fully digested ^[7]. Whether food staying longer in the stomach explains burping on tirzepatide has not been measured.

Many people describe the smell of these burps as sulfur-like. None of the Mounjaro® documents describes the smell of burps, and we found no study measuring it for tirzepatide, so this page does not offer an explanation.

Other reasons for more burping

Swallowing air is the most common cause of frequent belching. It happens when people eat or drink fast, talk while eating, chew gum, suck hard sweets, drink fizzy drinks, smoke, wear loose dentures or breathe through the mouth, for example with congestion or a CPAP mask at night ^[8][9].

Foods such as beans, lentils, cabbage, onions and broccoli can add gas ^[9]. Belching can also come with reflux disease, functional dyspepsia, gastritis, stomach ulcers, Helicobacter pylori infection, lactose intolerance, small intestinal bacterial overgrowth and rumination syndrome ^[9]. Diabetes itself is the most common known cause of gastroparesis, one of whose symptoms is excessive belching ^[11].

When a burp is part of something else

Mounjaro® is also approved to cut the chance of heart attack, stroke or heart death in adults with type 2 diabetes who are at high risk, and its heart-outcomes trial enrolled people with established heart or blood vessel disease ^[1]. Cleveland Clinic notes that belching is not a typical sign of a heart attack, but that chest pain, especially severe, crushing or spreading to the arm or jaw, together with belching should be treated as an emergency; nausea, sweating and dizziness can also be part of a heart attack ^[9].

Within the stomach, Canada lists prolonged belching and bloating with pain and severe nausea and vomiting as possible gastroparesis, and asks people to stop Mounjaro® and get immediate help ^[4]. Severe, lasting stomach pain, sometimes spreading to the back, is the warning sign for pancreatitis in the US Medication Guide ^[2].

Ways to cut down swallowed air

The Mounjaro® documents give no specific advice for burping. The suggestions below come from the NIH and Cleveland Clinic and apply to belching in general.

• Eat slowly, sitting down, and avoid talking while you eat or drink ^[8][9].
• Skip chewing gum, hard sweets, drinking through a straw and fizzy drinks, including beer ^[8][9].
• Notice whether beans, lentils, cabbage or onions make a difference for you ^[9].
• Smaller, more frequent meals may help with gas symptoms; a doctor may suggest them ^[8].
• For a bout of trapped air, Cleveland Clinic suggests lying on your side or in a knee-to-chest position until it passes ^[9].
• If you smoke or wear dentures, ask about quitting support or a denture check ^[8]. Ask a pharmacist before adding over-the-counter remedies, since tirzepatide can change how tablets are absorbed ^[1].

Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.

When to get help